Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Migraine headache misconceptions: barriers to effective care.

Richard Wenzel1, Marcus Dortch, Roger Cady

  • 1Diamond Headache Clinic Inpatient Unit, Saint Joseph Hospital, Resurrection Health Care, Chicago, Illinois 60657, USA. rwenz@hotmail.com

Pharmacotherapy
|May 28, 2004
PubMed
Summary

Migraine is a neurologic condition, not vascular. Triptans are safe and effective for migraine treatment when used appropriately, contrary to common misconceptions. Pharmacists can improve patient care by addressing these myths.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Giving Away a Piece of Yourself.

Kidney360·2025
Same author

Migraine-Related Burden, Treatment Interventions, and Healthcare Experiences by Race and Ethnicity: Results of the Migraine Report Card Survey.

Journal of racial and ethnic health disparities·2025
Same author

Misattributed paternity discovery: A critique of medical organizations' recommendations.

American journal of human genetics·2025
Same author

Response to the letter to the editor regarding "The efficacy of an alcohol-based nasal antiseptic versus mupirocin or an iodophor for preventing SSIs using a meta-analysis".

American journal of infection control·2025
Same author

Eptinezumab treatment was associated with longer interictal headache/migraine periods which corresponded to greater improvements in patient-reported quality of life measures.

Journal of neurology·2024
Same author

Headache-related stigma and quality of life in adults with frequent headaches/migraine and frequent medication use: a plain language summary.

Pain management·2024

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Migraine affects 12% of US adults, causing significant economic loss.
  • Pharmacists often lack adequate training in migraine therapy.
  • Common misconceptions hinder effective migraine management.

Purpose of the Study:

  • To refute common misconceptions about migraine pathophysiology and treatment.
  • To highlight the neurologic basis of migraine and the safety of triptans.
  • To emphasize the economic impact of migraine and the importance of appropriate therapy.

Main Methods:

  • Review of current understanding of migraine pathophysiology.
  • Analysis of clinical data and real-world experience with triptan medications.
  • Discussion of economic impact and treatment goals.

Related Experiment Videos

Main Results:

  • Migraine is a neurologic disorder of the trigeminovascular system; vascular effects are secondary.
  • Triptans have a benign adverse-effect profile, especially when used early in an attack.
  • Migraine causes billions in lost productivity; restoring function is the primary treatment goal.

Conclusions:

  • Pharmacists can play a crucial role in educating patients and correcting misconceptions about migraine.
  • Migraine-specific therapies, like triptans, are underutilized while less effective options are overused.
  • Addressing misconceptions and improving pharmacist training will benefit patients and the healthcare system.